期刊文献+

中医药防治非酒精性脂肪性肝病的遗传学思路探讨 被引量:1

The Genetics Study of TCM Prevention from Nonpalcoholic Fatty Liver Disease
下载PDF
导出
摘要 目前中医药防治非酒精性脂肪性肝病(NAFLD)的遗传学研究开展得较少。将NAFLD遗传学研究技术、方法、成果与中医药相结合,既是挑战也是机遇。基于转化医学的理念,将实验室与临床相结合,应用新技术、新方法探寻以临床实践为根本的中医药防治NAFLD的遗传学基础,将中医实践中观察到的问题进行进一步的实验验证,二者相互影响,更能促进实现中医诊治NAFLD的客观化、规范化和个体化,提升治疗效果。 At presentthere is relatively few research on TCM prevention from nonalcoholic fatty liver disease(NAFLD) based on transformation medicine. Therefore it is not only a challenge but also an opportunity to connect TCM with technology, methods, and results of NAFLD genetics research. Based on the concept of transformation medicine,laboratory and clinical practice is connected, new technology and methods are explored to look for TCM prevention from NAFLD on the basis of clinical practice, to observe the practical problems which are further experimented. They can influence each other to promote objectification, standardization and individualization of TCM prevention from NAFLD to improve the therapeutic effect.
机构地区 暨南大学医学院
出处 《河南中医》 2014年第6期1078-1080,共3页 Henan Traditional Chinese Medicine
关键词 非酒精性脂肪性肝病 遗传学 转化医学 中医药 nonalcoholic fatty liver disease(NAFLD) genetics transformation medicine traditional Chinese Medicine(TCM)
  • 相关文献

参考文献20

  • 1Everhart J E,Bambha K M.Fatty liver:think globally[J].Hepatology,2010,51(5):1491-1493.
  • 2Bellentani S,Scaglioni F,Marino M,et al.Epidemiology of nonalcoholic fatty liver disease[J].Digestive Diseases,2010,28(1):155-161.
  • 3Romeo S,Kozlitina J,Xing C,et al.Genetic variation in PNPLA3confers susceptibility to nonalcoholic fatty liver disease[J].Nature genetics,2008,40(12):1461-1465.
  • 4Valenti L,Al‐Serri A,Daly AK,et al.Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease[J].Hepatology,2010,51(4):1209-1217.
  • 5Sookoian S,Castano GO,Burgueno AL,et al.A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity[J].Journal of lipid research,2009,50(10):2111-2116.
  • 6Rotman Y,Koh C,Zmuda J M,et al.The association of genetic variability in patatin‐like phospholipase domain‐containing protein 3(PNPLA3)with histological severity of nonalcoholic fatty liver disease[J].Hepatology,2010,52(3):894-903.
  • 7Kitamoto T,Kitamoto A,Yoneda M,et al.Genome-wide scan revealed that polymorphisms in the PNPLA3,SAMM50,and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan[J].Hum Genet,2013,132(7):783-792.
  • 8Kawaguchi T,Sumida Y,Umemura A,et al.Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese[J].PloS one,2012,7(6):e38322.
  • 9Yuan X,Waterworth D,Perry J R B,et al.Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes[J].The American Journal of Human Genetics,2008,83(4):520-528.
  • 10Chambers J C,Zhang W,Sehmi J,et al.Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma[J].Nature genetics,2011,43(11):1131-1138.

二级参考文献26

共引文献36

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部